Early Phase 1 Alzheimer's Disease Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Adults aged 70 to 80 years old who report that their thinking and memory are working well and that they can manage everyday tasks independently.
- People who score 26 or higher on a standard memory and thinking test called the MoCA (Montreal Cognitive Assessment).
- People who have an elevated level of a specific protein called p-tau181 in their blood, which can be associated with brain changes.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have certain movement-related neurological signs, a documented stroke, or a diagnosis of multi-infarct dementia or fronto-temporal dementia, as determined by a specialist neurologist.
- People with active cancer, serious heart or lung disease, or another medical condition that could make it difficult for doctors to properly assess them and complete follow-up visits.
- People who are currently being treated with steroid medications (glucocorticoids), long-term immune-suppressing medications, or who currently live with someone who has a weakened immune system, due to safety concerns related to a live vaccine used in this trial.
- People who show a skin reaction larger than 10mm at 48 hours after an initial tuberculin skin test (PPD test).
- People who are unable to provide written consent to participate due to a psychiatric condition or a condition affecting their thinking and memory.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Plasma phosphorylated Tau (p-tau181) biomarker level, measured in picogram/ml by SIMOA technology.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.